Astellas Venture Management

Funding rounds backed by Astellas Venture Management.

Export CSV
Funding disclosed in full
$151.4M
Median round
$75.7M
Rounds in calculation
2
2 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Syntax Bio

Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine

$14.4MSeries A+BiotechUnited States
16 participantsAllegis CapitalAstellas Venture ManagementCivilization VenturesDCVC BioDraper AssociatesEGB CapitalExit FundIllinois VenturesIllumina VenturesLongGameMansueto OfficeMayo ClinicPortal InnovationsSigma Groupthe Illinois Department of Commerce and Economic OpportunityWalder Ventures
Sidewinder Therapeutics

Develops next-generation bispecific ADCs for cancer treatment

$137MSeries BBiotechUnited States
9 participantsAlexandria Real Estate EquitiesAstellas Venture ManagementDCVC BioFrazier Life SciencesGoldman Sachs Alternatives Life SciencesLongwood FundNovartis Venture FundOrbiMedSamsara BioCapital